Insider Buying: Innovotech (CVE:IOT) Director Acquires C$10,800.00 in Stock

Innovotech Inc. (CVE:IOT) Director Craig Milne purchased 135,000 shares of the business’s stock in a transaction that occurred on Friday, July 3rd. The stock was acquired at an average price of C$0.08 per share, with a total value of C$10,800.00. Following the purchase, the director owned 1,733,615 shares in the company, valued at C$138,689.20. This represents a 8.44% increase in their ownership of the stock.

Innovotech Stock Performance

CVE IOT opened at C$0.09 on Tuesday. The stock has a market capitalization of C$4.90 million, a price-to-earnings ratio of -13.22 and a beta of 2.64. The stock has a 50-day moving average of C$0.13 and a 200 day moving average of C$0.19. The company has a current ratio of 2.63, a quick ratio of 5.81 and a debt-to-equity ratio of 12.55. Innovotech Inc. has a twelve month low of C$0.08 and a twelve month high of C$0.34.

About Innovotech

Innovotech Inc provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services.